Elzonris for Blastic Plasmacytoid Dendritic Cell Neoplasm
Siklos for Recurrent Sickle Cell Anemia Pain
Xospata for Relapsed or Refractory AML
Firdapse for LEMS in Adults
Vitrakvi for Adult and Pediatric Solid Tumors
Gamifant for Primary Hemophagocytic Lymphohistiocytosis
Daurismo for Newly Diagnosed AML
Aemcolo for Noninvasive Escheria coli Infection
Yupelri for Chronic Obstructive Pulmonary Disease
Xofluza for Acute Uncomplicated Influenza
Talzenna for gBRCAm HER2-negative Locally Advanced or Metastatic Breast Cancer
Tegsedi for Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
Revcovi for Adenosine Deaminase Severe Combined Immune Deficiency
Nuzrya for CAPB or ABSSI
Tecentriq for Locally Advanced or Metastatic Urothelial Carcinoma
Generic Albenza Pills Now Available for Tapeworm, Parasite Infections
Duvelisib for Relapsed or Refractory CLL/SLL
The 10 Most Exciting Drugs in the 2019 Pipeline
Approved and upcoming drugs to look forward to this year.
Dacomitinib Approved for Non-Small Cell Lung Cancer
Approved by the FDA in September, this new drug serves as a first-line therapy for patients with particular metastatic non-small lung cancer.
The Smart Technology That Will Change Diabetes Care
GPS-based dietary prompts, continuous glucose monitors among the devices poised to revolutionize diabetes treatment and patient management.
Vaccine to Prevent Recurring Strokes Shows Early Promise
Research in mice has found that a vaccine may be able to help prevent the recurrence of strokes.
Andexxa for Reversal of Factor Xa Inhibitors
The 28 Latest Drug Approvals
What you need to know about the FDA’s most recent novel drug approvals.
What Pharmacists Need to Know About Lofexidine
FDA approves lofexidine for opioid withdrawal symptoms.
What Pharmacists Need to Know About Epidiolex
The FDA recently approved cannabidiol oral solution to treat seizures.
What Pharmacists Need to Know About Erenumab-aooe
The latest New Drug Review covers Amgen’s migraine medication.
FDA Approves First Fast-Track Generic
The drug is the first approved under the agency's new, quicker generic approval designation.
Avatrombopag for Thrombocytopenia in Adults
Our latest New Drug Review covers Dova’s most recent medication.
The 10 Latest Novel Drug Approvals
A roundup of the 10 most recent FDA-approved medications.
Betrixaban for Prophylaxis of Venous Thromboembolism
Betrixaban has been approved by the FDA for patients at risk for thromboembolisms.
